ID

31658

Description

GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01487720

Lien

https://clinicaltrials.gov/show/NCT01487720

Mots-clés

Versions (1)
  1. 17/09/2018 17/09/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

17 septembre 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer NCT01487720

Anglais

Eligibility Prostate Cancer NCT01487720

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed adenocarcinoma of the prostate
Description

Adenocarcinoma of prostate

Type de données

boolean

Alias
UMLS CUI [1]
C0007112
clinical or radiologic evidence of metastatic disease
Description

Neoplasm Metastasis

Type de données

boolean

Alias
UMLS CUI [1]
C0027627
documented disease progression during hormone therapy (adt plus antiandrogen) and no response to adt withdrawal
Description

Disease Progression During Hormone Therapy | Antiandrogen therapy | Androgen Antagonists | Antiandrogen therapy Withdrawal Without Response

Type de données

boolean

Alias
UMLS CUI [1,1]
C0242656
UMLS CUI [1,2]
C0347984
UMLS CUI [1,3]
C0279025
UMLS CUI [2]
C0279492
UMLS CUI [3]
C0002842
UMLS CUI [4,1]
C0279492
UMLS CUI [4,2]
C2349954
UMLS CUI [4,3]
C0332288
UMLS CUI [4,4]
C1704632
docetaxel-refractory disease defined as disease progression documented either during treatment of within 60 days after the cessation of treatment with docetaxel
Description

Docetaxel Refractory Disease | Disease Progression During Therapeutic procedure | Disease Progression Post Cessation Docetaxel

Type de données

boolean

Alias
UMLS CUI [1,1]
C0246415
UMLS CUI [1,2]
C1514815
UMLS CUI [2,1]
C0242656
UMLS CUI [2,2]
C0347984
UMLS CUI [2,3]
C0087111
UMLS CUI [3,1]
C0242656
UMLS CUI [3,2]
C0687676
UMLS CUI [3,3]
C1880019
UMLS CUI [3,4]
C0246415
prior exposure to estramustine or mitoxantrone is allowed
Description

Exposure to Estramustine | Exposure to Mitoxantrone

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C0014921
UMLS CUI [2,1]
C0332157
UMLS CUI [2,2]
C0026259
kps ≥ 60
Description

Karnofsky Performance Status

Type de données

boolean

Alias
UMLS CUI [1]
C0206065
no prior radioisotope therapy
Description

Radioisotope therapy Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0203608
UMLS CUI [1,2]
C0332197
no prior radiotherapy 25% or more of the bone marrow
Description

Absence Therapeutic radiology procedure Bone Marrow Percentage

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C1522449
UMLS CUI [1,3]
C0005953
UMLS CUI [1,4]
C0439165
no peripheral neuropathy grade 2 or worse
Description

Peripheral Neuropathy CTCAE Grades

Type de données

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C1516728
adequate organ and bone marrow function
Description

Organ function | Bone Marrow function

Type de données

boolean

Alias
UMLS CUI [1]
C0678852
UMLS CUI [2,1]
C0005953
UMLS CUI [2,2]
C0031843
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
other tumor type than adenocarcinoma
Description

Cancer Other | Exception Adenocarcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0001418
presence or history of cns metastasis
Description

CNS metastases

Type de données

boolean

Alias
UMLS CUI [1]
C0686377
other serious illness or medical conditions
Description

Illness Serious | Other medical condition Serious

Type de données

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0205404
Retour au début de la page

Similar models

Eligibility Prostate Cancer NCT01487720

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of prostate
Item
histologically or cytologically confirmed adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
Neoplasm Metastasis
Item
clinical or radiologic evidence of metastatic disease
boolean
C0027627 (UMLS CUI [1])
Disease Progression During Hormone Therapy | Antiandrogen therapy | Androgen Antagonists | Antiandrogen therapy Withdrawal Without Response
Item
documented disease progression during hormone therapy (adt plus antiandrogen) and no response to adt withdrawal
boolean
C0242656 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C0279025 (UMLS CUI [1,3])
C0279492 (UMLS CUI [2])
C0002842 (UMLS CUI [3])
C0279492 (UMLS CUI [4,1])
C2349954 (UMLS CUI [4,2])
C0332288 (UMLS CUI [4,3])
C1704632 (UMLS CUI [4,4])
Docetaxel Refractory Disease | Disease Progression During Therapeutic procedure | Disease Progression Post Cessation Docetaxel
Item
docetaxel-refractory disease defined as disease progression documented either during treatment of within 60 days after the cessation of treatment with docetaxel
boolean
C0246415 (UMLS CUI [1,1])
C1514815 (UMLS CUI [1,2])
C0242656 (UMLS CUI [2,1])
C0347984 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
C0242656 (UMLS CUI [3,1])
C0687676 (UMLS CUI [3,2])
C1880019 (UMLS CUI [3,3])
C0246415 (UMLS CUI [3,4])
Exposure to Estramustine | Exposure to Mitoxantrone
Item
prior exposure to estramustine or mitoxantrone is allowed
boolean
C0332157 (UMLS CUI [1,1])
C0014921 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0026259 (UMLS CUI [2,2])
Karnofsky Performance Status
Item
kps ≥ 60
boolean
C0206065 (UMLS CUI [1])
Radioisotope therapy Absent
Item
no prior radioisotope therapy
boolean
C0203608 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Absence Therapeutic radiology procedure Bone Marrow Percentage
Item
no prior radiotherapy 25% or more of the bone marrow
boolean
C0332197 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
C0005953 (UMLS CUI [1,3])
C0439165 (UMLS CUI [1,4])
Peripheral Neuropathy CTCAE Grades
Item
no peripheral neuropathy grade 2 or worse
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Organ function | Bone Marrow function
Item
adequate organ and bone marrow function
boolean
C0678852 (UMLS CUI [1])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Cancer Other | Exception Adenocarcinoma
Item
other tumor type than adenocarcinoma
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0001418 (UMLS CUI [2,2])
CNS metastases
Item
presence or history of cns metastasis
boolean
C0686377 (UMLS CUI [1])
Illness Serious | Other medical condition Serious
Item
other serious illness or medical conditions
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial